Press Releases in 2013

Novus Biologicals is excited to announce over 50+ new products added to the catalog.  Fifty monoclonal antibodies were released for research on epigenetics, neuroscience, apoptosis, cancer and more.  All of the newly released products can be viewed on the website at https://www.novusbio.com/new-product-information-page.html along with the validation data and detailed product information.  

The 2013 first quarter Novus Travel Grant winner is Helen Chen of the University of British Columbia, selected for her excellent review of our TPX2 Antibody NB100-78473.  Congratulations to Helen Chen, and thanks to all of our participants!  Helen will receive a $500 travel grant covering airfare and conference registration.  Participants had to submit a descriptive review and high quality image to be included into the Travel Grant drawing.

Novus Biologicals, a global supplier of high quality antibodies and research reagents for the life science research community has hired Tom Maslanik as a Product Manager to lead developing opportunities for flow cytometry.

In this rapidly growing consumables market, Maslanik said "I am extremely fortunate to be joining Novus during a period of innovation and rapid growth.  I am immediately impressed with their strategic vision and excited to contribute to the continued success of the company."

Novus Biologicals launched a new promotion today for 20% off on select FLOW antibodies.

“Novus is proud to be a leading supplier of top quality flow cytometry validated research antibodies. We hope this promotion will allow our customers to progress their research using our excellent selection of flow cytometry antibodies and wide variety of Lightning-Link conjugation kits” said Marketing Manager, David Stegemeier.  

Novus is working with a new antibody search engine called CiteAb to ensure antibodies are easy to find and that researchers can quickly see where they have been cited in the past.

Novus Biologicals, a leading provider of antibodies and research reagents, has developed several new features with the latest website release.    

“Our most recent website release includes many minor enhancements to usability and performance.  Most notable among those is our newly designed, more user friendly menu, expanded product listing options, faxable order forms and improved ability to share your shopping cart” added Zach Brooks, IT Manager.  

To further facilitate scientific research and discovery, Novus has launched a new Innovator’s Reward Program.  The Innovator’s Reward Program has been designed for researchers to test antibodies in a previously untested species or applications with minimal financial risk.

Novus Biologicals LLC, a leading  provider of antibodies and reagents to the life science research community has hired David Eansor to lead a new corporate-development effort.

The first quarter Novus Travel Grant winner is Dr. Gail M. Seigel of the University at Buffalo, selected for her excellent review of our Laminin Antibody (NB300-144).  Congratulations to Dr. Seigel, and thanks to all of our participants!  Dr. Seigel will receive a $500 travel grant covering airfare and conference registration.